Journal article icon

Journal article

A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance

Abstract:
Disulfiram, known as Antabuse®, is an oral drug for the treatment of alcohol dependence. Previous studies have indicated that disulfiram (DSF) exhibits antibacterial effects, particularly against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Our study delves into the antibacterial mechanism of DSF in MRSA through High-Pressure Liquid Chromatography (HPLC) metabolomics, investigating the underlying mechanism of DSF effects on thiamine and amino acid metabolism. Thiamine pyrophosphate (TPP) plays a crucial role as a cofactor for critical enzymes such as transketolase, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase. These enzymes are integral to the carbohydrate metabolism process within bacterial cells. TPP also contributes to coenzyme A (CoA) biosynthesis, identified as a prospective drug target for DSF in MRSA. Recent research highlighted DSF\u27s role in lowering intracellular CoA levels in MRSA, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways helped to uncover enriched genes related to the biosynthesis of TPP. Our transcriptome data further illuminated different amino acid metabolism shifts within DSF-treated MRSA. In-depth HPLC investigations utilized various methods to gauge TPP and amino acid levels in DSF-treated MRSA. These HPLC results effectively validated our hypothesis, confirming DSF\u27s influence on increasing cellular levels of TPP and amino acids like glutamate, glutamine, arginine, glycine, β-alanine, and lysine. Notably, our study also revealed diminished cellular levels of aspartate, valine, phenylalanine, and threonine. Our comprehensive study offers further insight on why DSF treatment alters TPP and select amino acid levels. These findings add to our understanding of DSF\u27s antibacterial mechanism in MRSA
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s13643-021-01794-3

Authors

More by this author
Role:
Author
ORCID:
0000-0002-7707-2729
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7970-039X
More by this author
Role:
Author
ORCID:
0000-0003-2217-2930


More from this funder
Funder identifier:
10.13039/100000865
Grant:
OPP1202541
More from this funder
Funder identifier:
10.13039/501100000683
Grant:
16109569
16109569
More from this funder
Funder identifier:
10.13039/100000877


Publisher:
BioMed Central
Journal:
Systematic Reviews More from this journal
Volume:
10
Issue:
1
Pages:
242-242
Article number:
242
Publication date:
2021-09-07
DOI:
EISSN:
2046-4053
ISSN:
2046-4053


Language:
English
Keywords:
Pubs id:
1311646
Local pid:
pubs:1311646
Source identifiers:
W3111984094
Deposit date:
2026-04-30
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP